Micron Technology
MU
ASML Holding
ASML
Taiwan Semiconductor
TSM
Meta Platforms
META
NVIDIA
NVDA
US Stock MarketDetailed Quotes
LYEL Lyell Immunopharma
- 0.678
- -0.020-2.85%
Close Jan 6 16:00 ET
- 0.678
- 0.0000.00%
Post 16:01 ET
198.09MMarket Cap-0.86P/E (TTM)
0.717High0.671Low876.75KVolume0.707Open0.698Pre Close606.86KTurnover0.41%Turnover RatioLossP/E (Static)292.16MShares3.25652wk High0.37P/B146.81MFloat Cap0.58252wk Low--Dividend TTM216.54MShs Float19.840Historical High--Div YieldTTM6.63%Amplitude0.582Historical Low0.692Avg Price1Lot Size
Lyell Immunopharma Key Stats
EPS
According to the latest financial report of Lyell Immunopharma, the latest earnings per share (TTM) for the company is -0.17. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Lyell Immunopharma's free cash flow? The latest report shows it as -35.10M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Lyell Immunopharma shows that the company's current ratio is 13.43, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Lyell Immunopharma, the quick ratio is 13.15, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Lyell Immunopharma? The latest ROE figure is -8.13%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Lyell Immunopharma, the total asset return on investment (ROA) is -7.00%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Lyell Immunopharma's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Lyell Immunopharma, the net profit margin is -131.13K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.